Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase EARLY_PHASE1 1Phase 1/2 1Phase 1 1

Status

Terminated 2Active not recruiting 2Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 5OTHER_GOV 1

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Breast 6

Conditions

Breast Neoplasms 10184Triple Negative Breast Neoplasms 1046Neoplasms 574Ovarian Neoplasms 564Neoplasm Metastasis 515Colorectal Neoplasms 473Carcinoma, Non-Small-Cell Lung 468Prostatic Neoplasms 440Lung Neoplasms 433Pancreatic Neoplasms 312Melanoma 299Stomach Neoplasms 295Breast Neoplasms, Male 257Motor Activity 252Colonic Neoplasms 238Uterine Cervical Neoplasms 227Endometrial Neoplasms 223Head and Neck Neoplasms 218Carcinoma, Intraductal, Noninfiltrating 217Carcinoma, Renal Cell 192Squamous Cell Carcinoma of Head and Neck 181Sarcoma 177Urinary Bladder Neoplasms 159Esophageal Neoplasms 155Brain Neoplasms 155Breast Carcinoma In Situ 154Lymphedema 148Fatigue 136Carcinoma, Ovarian Epithelial 134Small Cell Lung Carcinoma 130

Interventions

Fulvestrant 2vistusertib 1proto-oncogene protein c-fes-fps 1capivasertib 1Transurethral Resection of Bladder 1Hydroxychloroquine 1Everolimus 1Estrogens 1Estradiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Estrogen Receptor Positive Breast Cancer × Breast × Clear all
NCT01992952 2025-11-26

FAKTION

Velindre NHS Trust

Phase 1/2 Active not recruiting
149 enrolled
Breast

Estrogen Receptor Positive Breast Cancer

NCT06629233 2025-08-29

Tn-Miner

University Ghent

Phase NA Enrolling by invitation
36 enrolled
Breast

Estrogen Receptor Positive Breast Cancer

NCT02238808 2025-06-26

PRESTO

AHS Cancer Control Alberta

Phase 2 Active not recruiting
19 enrolled
Breast

Estrogen Receptor Positive Breast Cancer

NCT02216786 2024-12-02

MANTA

Queen Mary University of London

Phase 2 Completed
333 enrolled
Breast

Estrogen Receptor Positive Breast Cancer

NCT04727632 2024-10-28

[18F]Fluoroestradiol-PET/CT Companion Imaging Study to the FORESEE Trial

University of Utah

Phase EARLY_PHASE1 Terminated
2 enrolled
Breast

Estrogen Receptor Positive Breast Cancer

NCT02414776 2017-09-27

ABC01

Western Regional Medical Center

Phase 1 Terminated
3 enrolled
Breast

Estrogen Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡